Downloaded from https://www.everyspec.com local, State, and Federal regulations. Note. Disposal planning will be conducted during the risk assessment process (see para 20–4). 20–14. Biological program safety studies and reviews Safety studies and reviews are conducted to assure that maximum safety and occupational health measures are implemented to prevent mishaps involving IAT. Any HQDA agency may recommend a special study or review of an infectious agent or toxin operation or safety control when it becomes necessary to investigate the condition or changes described below. The responsible HQDA agency will determine the scope and conduct the study or review.
Special study activities will be coordinated with Office of the Director of Army Safety (DACS–SF), 200 Army Pentagon, Washington, DC 20310–0200 and will include an analysis of— a. Conditions or practices that may affect safety. b. Major system modifications including both design and physical configuration changes. c. Significant changes to safety, health, and environmental protection standards and requirements that affect biologi- cal operations. 20–15.
Contracting Contracting officers will ensure that Army biological safety clauses are made contractually binding on all contractors required to posses or use Army- or DOD-provided IAT, with the exception of clinical diagnostic, epidemiologic, and surveillance specimens. a. The contracting officer will designate a COR to monitor the contract. b. At the conclusion of the contract, the contractor will manage the final disposition of the IAT in accordance with the plan specified in the contract. c. The AMC and MEDCOM are jointly responsible for developing the biological safety contract clauses, including clauses for accident and incident investigation and reporting.
The AMC and MEDCOM will ensure that such clauses are promulgated in accordance with FAR, subparts 1.3 and 1.4, Defense FAR supplement, Subparts 201.3 and 201.4, and the Army FAR supplement, subparts 5101.3 and 5101.4. d. Contract clauses will be maintained by ODASAF with assistance from the AMC and MEDCOM. e. Each contracting officer will ensure that contract facilities handling Army- or DOD-supplied IAT are preinspected per the appropriate checklist in DA Pam 385–69 and annually inspected for compliance with biological safety clauses and DA Pam 385–69. Chapter 21 Chemical Agent Safety Management 21–1. Introduction a.
This chapter prescribes DA safety policy and processes for the Army chemical agent safety function. b. This chapter applies to blister agents H, HD, HT, and L and to nerve agents GA, GB, GD, GF, and VX and other experimental chemical agents exhibiting toxicity similar to nerve and blister agents. This chapter does not apply to commercially available or produced chemicals or to RCWM. c. DA Pam 385–61 contains technical safety and occupational health requirements for developing management and control processes for operations involving chemical agents and associated weapons systems. Its implementation is mandatory.
DA Pam 385–61 is a guide for contingency or tactical military operations and not mandatory. d. DA Pam 385–61, chapter 12, applies only to chemical agent training at the Chemical Defense Training Facility, at the U.S. Army Chemical School, Fort Leonard Wood, MO. e. Chemical agent waste associated with chemical agent facilities and operations, which does not meet the definition of clean, will be managed, stored, and shipped in accordance with existing laws and regulations to a permitted treatment, storage, or disposal facility whose permit allows receipt of such wastes. f.
The requirements of DA Pam 385–61 do not apply to RDT&E solutions of chemical agents defined in AR 50–6 as RDT&E dilute solutions. (1) The provisions contained in DA Pam 385–61 should be used as a guide in conjunction with a hazard analysis, SOPs, and good laboratory practices to ensure safe operations with RDT&E solutions. (2) Each installation or activity conducting RDT&E solution operations must have a program document that describes how these operations will be conducted. 21–2. Applicability This chapter applies to activities and organizations with a mission involving chemical agents and applies during peacetime, wartime, contingency operations, training, exercises, and RDT&E.
80 AR 385–10 • 23 August 2007/RAR 4 October 2011